Key points: GI side effects are most common: nausea, diarrhea, and decreased appetite They usually improve: most patients adapt within 4-8 weeks Start low, go slow: the escalation schedule exists for a reason Stay hydrated and modify your diet: simple changes make a big difference Communicate with your provider: don't suffer unnecessarily Sources SURMOUNT-1 Clinical Trial (Jastreboff et al., NEJM 2022) SURPASS-1 Clinical Trial (Rosenstock et al., NEJM 2021) Mounjaro Prescribing Information, Eli Lilly Zepbound Prescribing Information, Eli Lilly Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice
Trophic Support (hormonal support for healing, restoring and regenerating brain cells): Vitamin D *
The end-result: DNA damage, cell damage, and aging
If you plateau despite dose increases, your genetic insights reveal whether a therapy combination would outperform semaglutide alone
Long-term outcomes of responders in a randomized, controlled phase II trial of aptamer AS1411 in AML
